Login
$HURA
$2.04 -$0.14 (6.42%) Close

$HURA 4 SEC Filings

Filed On Filing
29 May 2026 Form 4: Bianco James A., Director

Gave 150,000 shares as a gift

17 Feb 2026 Form 4: Tendler Craig, Director

Granted 156,240 Options (Right to Buy)

17 Feb 2026 Form 4: Ng George K, Director

Granted 156,240 Options (Right to Buy)

17 Feb 2026 Form 4: Manuso James S J, Director

Granted 156,240 Options (Right to Buy)

17 Feb 2026 Form 4: List Alan, Director

Granted 156,240 Options (Right to Buy)

17 Feb 2026 Form 4: Hoffman Robert E., Director

Granted 156,240 Options (Right to Buy)

08 Jan 2026 Form 4: Dearborn Dan, Chief Financial Officer

Granted 273,696 Options (Right to Buy)

08 Jan 2026 Form 4: Bianco James A., Director

Granted 610,332 Options (Right to Buy)

17 Dec 2025 Form 4: Dearborn Dan, Chief Financial Officer

Granted 1,531,367 Options (Right to Buy)

17 Dec 2025 Form 4: Bianco James A., Director

Granted 3,414,891 Options (Right to Buy)

19 Mar 2025 Form 4: Tendler Craig, Director

Granted 151,883 Options (Right to Buy)

06 Jan 2025 Form 4: Hoffman Robert E., Director

Granted 51,275 Options (Right to Buy)

06 Jan 2025 Form 4: Manuso James S J, Director

Granted 59,590 Options (Right to Buy)

06 Jan 2025 Form 4: List Alan, Director

Granted 51,275 Options (Right to Buy)

06 Jan 2025 Form 4: Ng George K, Director

Granted 51,275 Options (Right to Buy)

14 Nov 2024 Form 4: Bianco James A., Director

Granted 1,065,990 Options (Right to Buy)

14 Nov 2024 Form 4: Dearborn Dan, Chief Financial Officer

Granted 489,848 Options (Right to Buy)

22 Oct 2024 Form 4: Yamashita Dennis, Chief Scientific Officer

Granted 196,790 Options (Right to Buy)

22 Oct 2024 Form 4: Ng George K, Director

Granted 62,886 Options (Right to Buy)

22 Oct 2024 Form 4: List Alan, Director

Granted 27,106 Options (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support